Actualizado 01/06/2009 14:33
- Comunicado -

Encouraging First Data on New Targeted Treatment for Patients With Melanoma - the Deadliest Form of Skin Cancer (y 2)

Roche Group Media Relations: Phone: +41-61-688-8888, e-mail: basel.mediaoffice@roche.com; Daniel Piller (Head);Alexander Klauser; Martina Rupp; Claudia Schmitt; Nina Schwab-Hautzinger; Christine McMenamin, Roche, Tel: +41-79-618-7671, christine.mcmenamin@roche.com; Kathleen Sereda Glaub, Plexxikon Inc., Tel: +1-510-647-4009, kglaub@plexxikon.com; Anne Cameron, Galliard Healthcare, Tel: +44-759-0711-190, acameron@galliardhealth.com

Contenido patrocinado